Beth Chekemian, DO
Interventional Pain Medicine · Bensalem, PANPI 1154567311
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,068 of the $2,891 with a category attached, or 71.5%. Pacira Pharmaceuticals Incorporated accounts for 78.2% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $2,403, more than ten times the $12 reported in 2020. That places this record below the midpoint for interventional pain medicine clinicians in PA, where the typical reported total is $2,714.
Across 31 payments — averaging $93.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2K
- Boston Scientific$247
- Abbott$207
- AbbVie$50
- Stryker$37
- Bioventus LLC$34
- plus $55 from 2 others
What the payments were for
- Travel & lodging$2,06872%
- Food & beverage$82328%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 8 | $2,262 |
| Boston Scientific | 8 | $247 |
| Abbott | 8 | $207 |
| AbbVie | 2 | $50 |
| Stryker | 1 | $37 |
| Bioventus LLC | 1 | $34 |
| Vertos Medical, Inc. | 2 | $30 |
| Nalu Medical, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$2,145
How this compares
$2,891 in reported general payments places this provider in the 50th percentile of 59 interventional pain medicine providers in Pennsylvania.
See all interventional pain medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 24 | $4,518 |
| Gabapentin | 183 | $2,092 |
| Morphine Sulfate ErMorphine Sulfate | 74 | $1,947 |
| Lidocaine | 28 | $1,708 |
| Pregabalin | 106 | $1,334 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 74 | $1,152 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $994 |
| Tramadol Hcl ErTramadol Hcl | 13 | $720 |
| Oxycodone Hcl | 37 | $656 |
| Tramadol Hcl | 115 | $617 |
| Baclofen | 20 | $407 |
| Celecoxib | 68 | $353 |
| Tizanidine Hcl | 34 | $308 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 30 | $272 |
| Meloxicam | 34 | $222 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Bensalem
- Michael FishmanLebanon$670K
- David ProvenzanoSewickley$198K
- Michael FarrellPittsburgh$23K
- Farshad RashidianWest Chester$19K
- Chad MetzgerDarby$14K
- Jorge Rivero-BecerraPittsburgh$12K
- James BresnahanSpringfield$12K
- Jonathan SchollIndiana$11K
- Nathan MaltezosWest Chester$10K
- Mark BellPlains$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.